Results showed that the FAP-CAR T cells were powerfully potent in killing human and murine FAP-positive tumor cells and CAFs, and were biologically safe and exhibited low-level OTOT, warranting further clinical investigation into our FAP-CAR T cells. This evidence concerns the gene FAP and neoplasm.